Powered by Illumina sequencing technology, GRAIL will develop a pan-cancer screening test by directly measuring circulating nucleic acids in blood.
Grail | Pan-cancer blood screening test for circulating tumor DNA
Posted in biotech/medical
Posted in biotech/medical
Powered by Illumina sequencing technology, GRAIL will develop a pan-cancer screening test by directly measuring circulating nucleic acids in blood.